Tuberculous enteritis
ICD-10 A18.32 is a billable code used to indicate a diagnosis of tuberculous enteritis.
Tuberculous enteritis is a form of extrapulmonary tuberculosis that primarily affects the intestines, particularly the ileum. It is caused by Mycobacterium tuberculosis, the bacterium responsible for tuberculosis (TB). The condition can manifest with a variety of gastrointestinal symptoms, including abdominal pain, diarrhea, weight loss, and malabsorption. Diagnosis typically involves a combination of clinical evaluation, imaging studies such as CT scans or ultrasounds, and microbiological tests, including stool cultures and biopsies. Sputum tests and chest X-rays may also be performed to rule out pulmonary involvement. Treatment usually consists of a multi-drug regimen, including isoniazid, rifampicin, ethambutol, and pyrazinamide, administered over a period of at least six months. Monitoring for drug resistance is crucial, as resistance can complicate treatment and lead to poorer outcomes. Public health implications are significant, as TB is a contagious disease, necessitating contact tracing and isolation procedures for infected individuals to prevent transmission. The management of tuberculous enteritis requires a multidisciplinary approach, involving gastroenterologists, infectious disease specialists, and public health officials.
Detailed history of TB exposure, diagnostic test results, and treatment plans.
Patients presenting with gastrointestinal symptoms and a history of TB exposure.
Consideration of drug resistance and the need for follow-up testing.
Endoscopy reports, biopsy results, and imaging studies.
Patients with unexplained abdominal pain and weight loss.
Differentiating TB from other inflammatory bowel diseases.
Used to evaluate suspected intestinal TB.
Indication for procedure, findings, and biopsy results.
Gastroenterologists should document any findings that suggest TB.
Common symptoms include abdominal pain, diarrhea, weight loss, and malabsorption. Patients may also experience fever and night sweats.
Diagnosis typically involves clinical evaluation, imaging studies, and microbiological tests such as stool cultures and biopsies.
Treatment usually consists of a multi-drug regimen including isoniazid, rifampicin, ethambutol, and pyrazinamide, administered over a minimum of six months.
Due to its infectious nature, tuberculous enteritis requires contact tracing and isolation procedures to prevent transmission.
